# iShares STOXX Europe 600 Health Care UCITS ETF (DE) (0MP1)

**Page:** https://fundology.uk/fund/0mp1 · ISIN DE000A0Q4R36

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, 0MP1 (iShares STOXX Europe 600 Health Care UCITS ETF (DE), ISIN DE000A0Q4R36) closed at €126.81 on the London Stock Exchange. Its ongoing charge is 0.46% a year (about £46 on £10,000). Over the five years to 13/11/2026 its total return was +25.8%, or −1.8% after UK CPIH inflation.

## Summary

iShares STOXX Europe 600 Health Care UCITS ETF (DE) is an exchange-traded fund (ETF) from iShares, launched in 2001. It tracks the STOXX Europe 600 Health Care — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.46% a year — about £46 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year.

Latest close: **€126.81** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | 0MP1 |
| ISIN | DE000A0Q4R36 |
| Also listed as | EXV4 (Xetra, euros) |
| Category | Healthcare |
| Type | ETF |
| Provider | iShares |
| Tracks | STOXX Europe 600 Health Care |
| Income | Distributing |
| Ongoing charge | 0.46% a year (£46 per £10,000) |
| Fund size | £603m |
| Launched | 2001 |
| Domicile | Germany |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 01/03/2013 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +9.16% | +5.29% | income reinvested |
| 3 years | +25.20% | +13.11% | income reinvested |
| 5 years | +25.83% | -1.78% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of iShares STOXX Europe 600 Health Care UCITS ETF (DE) in pounds (price only, income paid out not included): 2022 −1.7%, 2023 +2.5%, 2024 −0.6%, 2025 +9.4%; 2026 to 13/11/2026 +6.6%. Returns of iShares STOXX Europe 600 Health Care UCITS ETF (DE) in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: −1.1%; to 30/09/2025: −5.3%; to 30/09/2024: +9.4%; to 30/09/2023: +11.7%; to 30/09/2022: −2.3%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -1.7% | -10.1% | Price |
| 2023 | +2.5% | -1.6% | Price |
| 2024 | -0.6% | -4.0% | Price |
| 2025 | +9.4% | +5.6% | Price |
| 2026 to 13/11/2026 | +6.6% | +3.2% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 17.93% | -13.10% |
| 3 years | 16.21% | -21.22% |
| 5 years | 15.59% | -21.22% |

## Largest fall

Volatility of iShares STOXX Europe 600 Health Care UCITS ETF (DE) in pounds, annualised from weekly returns to 13/11/2026: 17.9% over 1 year, 16.2% over 3 years, 15.6% over 5 years. Largest fall in the price of iShares STOXX Europe 600 Health Care UCITS ETF (DE) since November 2021, in pounds: −21.2% from 30/08/2024 to 11/04/2025. The lowest 12-month return of iShares STOXX Europe 600 Health Care UCITS ETF (DE) in pounds (price only, income paid out not included) since January 2021 was −17.9% (12 months to 08/08/2025); the highest was +21.9% (12 months to 08/04/2022). On 13/11/2026 the price of iShares STOXX Europe 600 Health Care UCITS ETF (DE) was 1.3% below its highest weekly close since November 2021 (30/08/2024), in pounds.

## Charges compared with similar funds

Ongoing charge of iShares STOXX Europe 600 Health Care UCITS ETF (DE) 0.46% a year. Compared on 14/11/2026, 6 of the 28 other healthcare funds charge more, 0 the same and 22 less (share classes counted once).

## Funds tracking the same index

2 funds track STOXX Europe 600 Health Care, this one included and share classes counted once; their ongoing charges range from 0.30% to 0.46% a year (13/11/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation | 0.30% | +9.0% | +25.3% | +25.9% |
| iShares STOXX Europe 600 Health Care UCITS ETF (DE) (this fund) | 0.46% | +9.2% | +25.2% | +25.8% |

Returns are as reported, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.46%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 06/11/2026, 0MP1 holds 47 positions, according to its published holdings. The largest is Roche Ps Par at 16.17% of the fund; the ten largest make up 73.0%.

### Top holdings

Largest positions (as of 06/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Roche Ps Par | — | 16.17% |
| 2 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 14.87% |
| 3 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 13.96% |
| 4 | Novo Nordisk · Class B | [NOVO_B](https://fundology.uk/stock/NOVO_B) | 6.24% |
| 5 | Sanofi | [SAN](https://fundology.uk/stock/EURONEXT:SAN) | 5.05% |
| 6 | GSK | [GSK](https://fundology.uk/stock/GSK) | 4.94% |
| 7 | EssilorLuxottica | [EL](https://fundology.uk/stock/EL) | 3.28% |
| 8 | Bayer | [BAYN](https://fundology.uk/stock/BAYN) | 2.94% |
| 9 | argenx | [ARGX](https://fundology.uk/stock/ARGX) | 2.76% |
| 10 | Lonza Group | [LONN](https://fundology.uk/stock/LONN) | 2.75% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

As published for the fund, as of 06/11/2026.

| Sector | Weight |
|---|---|
| Health Care | 97.5% |
| Personal & Household Goods | 2.1% |
| Cash and derivatives | 0.4% |

### By country

As published for the fund, as of 06/11/2026.

| Country | Weight |
|---|---|
| Switzerland | 41.9% |
| United Kingdom | 22.0% |
| Denmark | 10.1% |
| France | 10.1% |
| Germany | 7.4% |
| Belgium | 5.0% |
| Netherlands | 1.2% |
| Sweden | 1.1% |
| Other countries | 1.3% |

### By type of asset

Added up from the fund’s published holdings, as of 06/11/2026.

| Type of asset | Weight |
|---|---|
| Equity | 99.6% |
| Cash and money market | 0.4% |

All 50 holdings: https://fundology.uk/fund/0mp1/holdings

## Questions people ask

**What is the ongoing charge of 0MP1?**

The ongoing charge of 0MP1 is 0.46% a year — about £46 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of iShares STOXX Europe 600 Health Care UCITS ETF (DE) 0.46% a year. Compared on 14/11/2026, 6 of the 28 other healthcare funds charge more, 0 the same and 22 less (share classes counted once).

**What does 0MP1 track?**

0MP1 tracks the STOXX Europe 600 Health Care — large and medium-sized European companies.

**Is 0MP1 accumulating or distributing?**

0MP1 is distributing: income is paid out to holders as cash, usually a few times a year. It pays out quarterly.

**What is the ISIN of 0MP1?**

The ISIN of 0MP1 is DE000A0Q4R36. An ISIN identifies one exact share class of a fund; 0MP1 is its ticker on the London Stock Exchange. The same share class is also listed as EXV4 (Xetra, euros).

**What does 0MP1 hold?**

As of 06/11/2026, 0MP1 holds 47 positions, according to its published holdings. The largest is Roche Ps Par at 16.17% of the fund; the ten largest make up 73.0%. Its ten largest holdings are Roche Ps Par (16.17%), Novartis (14.87%), AstraZeneca (13.96%), Novo Nordisk · Class B (6.24%), Sanofi (5.05%), GSK (4.94%), EssilorLuxottica (3.28%), Bayer (2.94%), argenx (2.76%) and Lonza Group (2.75%).

**What were 0MP1’s returns in each of the last five years?**

Calendar-year returns of 0MP1 in pounds (price only, income paid out not included): 2022 −1.7%, 2023 +2.5%, 2024 −0.6%, 2025 +9.4%; 2026 to 13/11/2026 +6.6%. Past performance is not a guide to future returns.

**How has 0MP1 done after inflation?**

Over the five years to 13/11/2026 0MP1’s total return was +25.8%, or −1.8% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at iShares](https://www.ishares.com/uk/individual/en/products/251946/ishares-stoxx-europe-600-health-care-ucits-etf-de-fund)
- [Key investor information document (KIID)](https://www.ishares.com/gls-download/literature/kiid/ucits_kiid-ishares-stoxx-europe-600-health-care-ucits-etf-de-gb-de000a0q4r36-en.pdf)
- [Factsheet](https://www.ishares.com/gls-download/literature/fact-sheet/exv4-ishares-stoxx-europe-600-health-care-ucits-etf-de-fund-fact-sheet-en-gb.pdf)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.